Liver disease in autosomal recessive polycystic kidney disease
- PMID: 16176423
- DOI: 10.1111/j.1399-3046.2005.00342.x
Liver disease in autosomal recessive polycystic kidney disease
Abstract
Hepatic complications occur in a significant proportion of children with autosomal recessive polycystic kidney disease (ARPKD). PKHD1/fibrocystin, the defective gene in ARPKD, is expressed in the cilia of bile duct epithelium and leads to abnormalities in the rubric of the ductal plate malformation. Portal hypertension and biliary disease are the major liver problems seen in ARPKD. Complete blood counting, physical examination, ultrasonography and magnetic resonance (MR) cholangiography are indicated as screening procedures for hepatic disease in ARPKD. Medical and surgical interventions are potentially indicated for children with portal hypertension and/or biliary disease. A high index of suspicion for the diagnosis of cholangitis needs to be maintained in children with biliary disease. The implications of hepatic disease need to be considered in the decision-making regarding renal transplantation in ARPKD.
Similar articles
-
Liver disease in autosomal recessive polycystic kidney disease: clinical characteristics and management in relation to renal failure.J Pediatr Gastroenterol Nutr. 2014 Aug;59(2):190-6. doi: 10.1097/MPG.0000000000000422. J Pediatr Gastroenterol Nutr. 2014. PMID: 24806835
-
Predominant extrahepatic biliary disease in autosomal recessive polycystic kidney disease: a new association.Pediatr Transplant. 2006 May;10(3):294-8. doi: 10.1111/j.1399-3046.2005.00456.x. Pediatr Transplant. 2006. PMID: 16677351
-
A mouse model for cystic biliary dysgenesis in autosomal recessive polycystic kidney disease (ARPKD).Hepatology. 2005 May;41(5):1113-21. doi: 10.1002/hep.20655. Hepatology. 2005. PMID: 15830394
-
[From gene to disease; PKHD1 and recessive polycystic kidney disease].Ned Tijdschr Geneeskd. 2005 Feb 26;149(9):463-6. Ned Tijdschr Geneeskd. 2005. PMID: 15771341 Review. Dutch.
-
Molecular basis of autosomal recessive polycystic kidney disease (ARPKD).Adv Anat Pathol. 2008 Jan;15(1):54-8. doi: 10.1097/PAP.0b013e31815e5295. Adv Anat Pathol. 2008. PMID: 18156813 Review.
Cited by
-
Ameliorating liver disease in an autosomal recessive polycystic kidney disease mouse model.Am J Physiol Gastrointest Liver Physiol. 2023 May 1;324(5):G404-G414. doi: 10.1152/ajpgi.00255.2022. Epub 2023 Mar 7. Am J Physiol Gastrointest Liver Physiol. 2023. PMID: 36880660 Free PMC article.
-
Single-Center Experience of Pediatric Cystic Kidney Disease and Literature Review.Children (Basel). 2024 Mar 25;11(4):392. doi: 10.3390/children11040392. Children (Basel). 2024. PMID: 38671609 Free PMC article.
-
MicroRNA15a modulates expression of the cell-cycle regulator Cdc25A and affects hepatic cystogenesis in a rat model of polycystic kidney disease.J Clin Invest. 2008 Nov;118(11):3714-24. doi: 10.1172/JCI34922. Epub 2008 Oct 23. J Clin Invest. 2008. PMID: 18949056 Free PMC article.
-
Evidence for a "Pathogenic Triumvirate" in Congenital Hepatic Fibrosis in Autosomal Recessive Polycystic Kidney Disease.Biomed Res Int. 2016;2016:4918798. doi: 10.1155/2016/4918798. Epub 2016 Nov 7. Biomed Res Int. 2016. PMID: 27891514 Free PMC article. Review.
-
Persistent Hypoglycemia with Polycystic Kidneys: A Rare Combination - A Case Report.Biomed Hub. 2020 Dec 3;5(3):32-37. doi: 10.1159/000511389. eCollection 2020 Sep-Dec. Biomed Hub. 2020. PMID: 34055813 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases